Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.13B |
| 2 |
AT&T
T
|
+$275M |
| 3 |
Apple
AAPL
|
+$248M |
| 4 |
Walt Disney
DIS
|
+$235M |
| 5 |
Nike
NKE
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$863M |
| 4 |
Advanced Micro Devices
AMD
|
+$808M |
| 5 |
Amazon
AMZN
|
+$783M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.82% |
| 2 | Technology | 1.6% |
| 3 | Consumer Discretionary | 1.3% |
| 4 | Financials | 0.99% |
| 5 | Communication Services | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
PUT
PACCAR
PCAR
$66B
| $3.21M | ﹤0.01% |
54,600
-28,650
| -34% | -$1.66M |
|
4477
Jazz Pharmaceuticals
JAZZ
$15.9B
| $3.2M | ﹤0.01% |
25,146
-28,670
| -53% | -$3.77M |
|
4478
CALL
Codexis
CDXS
$174M
| $3.2M | ﹤0.01% |
102,300
+81,500
| +392% | +$2.68M |
|
4479
PUT
Takeda Pharmaceutical
TAK
$57.6B
| $3.2M | ﹤0.01% |
234,700
-596,300
| -72% | -$8.36M |
|
4480
CALL
Lazard
LAZ
$4.25B
| $3.2M | ﹤0.01% |
73,300
+36,600
| +100% | +$1.71M |
|
4481
PUT
Vanguard Energy ETF
VDE
$10.7B
| $3.2M | ﹤0.01% |
41,200
-63,900
| -61% | -$5.08M |
|
|
PENG
4482
Penguin Solutions Inc
PENG
$2.54B
| $3.2M | ﹤0.01% |
90,060
+50,966
| +130% | +$1.45M |
|
4483
PUT
Asbury Automotive
ABG
$3.8B
| $3.2M | ﹤0.01% |
18,500
+13,200
| +249% | +$2.43M |
|
4484
CALL
WEC Energy
WEC
$34.6B
| $3.19M | ﹤0.01% |
32,900
+11,400
| +53% | +$1.04M |
|
4485
CALL
Zentalis Pharmaceuticals
ZNTL
$360M
| $3.19M | ﹤0.01% |
38,000
-53,200
| -58% | -$4.12M |
|
4486
Sprott Physical Gold and Silver Trust
CEF
$7.99B
| $3.19M | ﹤0.01% |
179,988
-104,863
| -37% | -$1.86M |
|
4487
Conduent
CNDT
$267M
| $3.19M | ﹤0.01% |
597,688
+288,298
| +93% | +$1.72M |
|
4488
CALL
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$335M
| $3.19M | ﹤0.01% |
170,600
-150,300
| -47% | -$3.04M |
|
|
ONEM
4489
PUT
DELISTED
1Life Healthcare
ONEM
| $3.19M | ﹤0.01% |
181,700
-5,200
| -3% | -$101K |
|
4490
CALL
Crane NXT
CXT
$2.89B
| $3.18M | ﹤0.01% |
90,113
+39,443
| +78% | +$1.37M |
|
4491
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $3.18M | ﹤0.01% |
64,816
+24,726
| +62% | +$1.17M |
|
|
ROVR
4492
CALL
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $3.18M | ﹤0.01% |
326,100
-1,174,600
| -78% | -$13.6M |
|
|
DNB
4493
CALL
DELISTED
Dun & Bradstreet
DNB
| $3.18M | ﹤0.01% |
155,000
+7,100
| +5% | +$135K |
|
4494
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.88B
| $3.18M | ﹤0.01% |
26,813
+20,369
| +316% | +$2.37M |
|
4495
CALL
CDW
CDW
$18.5B
| $3.17M | ﹤0.01% |
15,500
-37,900
| -71% | -$7.21M |
|
4496
Vornado Realty Trust
VNO
$7.13B
| $3.17M | ﹤0.01% |
75,815
+543
| +0.7% | +$23.5K |
|
4497
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
| $3.17M | ﹤0.01% |
23,437
+3,271
| +16% | +$425K |
|
4498
Fair Isaac
FICO
$24.9B
| $3.17M | ﹤0.01% |
7,309
-112
| -2% | -$44.5K |
|
4499
First Trust US Equity Opportunities ETF
FPX
$1.48B
| $3.17M | ﹤0.01% |
+25,875
| New | +$3.28M |
|
|
REGI
4500
PUT
DELISTED
Renewable Energy Group, Inc.
REGI
| $3.17M | ﹤0.01% |
74,700
+1,800
| +2% | +$91.9K |
|
Similar funds
Jeff Yass's Q4 2021 Portfolio in Review
As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
- Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
- Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
- Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
- Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
- Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
- Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.